Marshall Wace’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.26M | Buy |
+447,807
| New | +$4.26M | ﹤0.01% | 1124 |
|
|
2025
Q1 | – | Sell |
-24,501
| Closed | -$577K | – | 2570 |
|
|
2024
Q4 | $577K | Buy |
+24,501
| New | +$577K | ﹤0.01% | 1848 |
|
|
2024
Q3 | – | Sell |
-273,567
| Closed | -$9.65M | – | 2396 |
|
|
2024
Q2 | $9.65M | Buy |
273,567
+219,862
| +409% | +$7.76M | 0.01% | 673 |
|
|
2024
Q1 | $1.52M | Buy |
+53,705
| New | +$1.52M | ﹤0.01% | 1290 |
|
|
2023
Q4 | – | Sell |
-22,052
| Closed | -$198K | – | 1942 |
|
|
2023
Q3 | $198K | Hold |
22,052
| – | – | ﹤0.01% | 1669 |
|
|
2023
Q2 | $248K | Sell |
22,052
-110,292
| -83% | -$1.24M | ﹤0.01% | 1766 |
|
|
2023
Q1 | $1.52M | Buy |
132,344
+110,292
| +500% | +$1.27M | ﹤0.01% | 1266 |
|
|
2022
Q4 | $256K | Sell |
22,052
-42,858
| -66% | -$497K | ﹤0.01% | 2033 |
|
|
2022
Q3 | $824K | Sell |
64,910
-284,369
| -81% | -$3.61M | ﹤0.01% | 1865 |
|
|
2022
Q2 | $2.4M | Hold |
349,279
| – | – | ﹤0.01% | 1514 |
|
|
2022
Q1 | $3.37M | Hold |
349,279
| – | – | 0.01% | 1423 |
|
|
2021
Q4 | $4.15M | Buy |
349,279
+327,227
| +1,484% | +$3.89M | 0.01% | 1297 |
|
|
2021
Q3 | $358K | Hold |
22,052
| – | – | ﹤0.01% | 2005 |
|
|
2021
Q2 | $464K | Buy |
+22,052
| New | +$464K | ﹤0.01% | 1695 |
|